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Real-Time Intracardiac Echocardiographic
Imaging of the Posterior Left Atrial Wall
Contiguous to Anterior Wall of the Esophagus
In a recent issue of the Journal, Good et al. (1) reported that
esophageal location and movement during left atrial ablation can
be detected using a barium ingestion–digital cine-fluoroscopic
imaging technique. The disadvantages of the barium ingestion–
cine-fluoroscopic imaging technique, which they used in the
report, include; 1) no real-time imaging during energy delivery of
the left atrial posterior wall contiguous to the anterior esophageal
wall, which is the most important/only region to be imaged and
protected; 2) gaps in barium contrast of the entire esophageal
mucosa border that may provide misleading information of the
extent of contact along the contiguous posterior left atrial wall;
3) an active effect of barium ingestion on esophageal luminal
diameter and movement; and 4) risk of aspiration. In addition,
Figures 1A and 1B in the report (1) compare differing anteropos-
terior projections, creating the illusion of movement that should
have been confirmed with the same angled projection.
Intracardiac echocardiography (ICE) can provide real-time
imaging of the left atrial posterior wall contiguous to the anterior
esophageal wall during energy delivery for left atrial ablation (2).
Our ICE studies of esophageal imaging in more than 235 patients
showed that the left atrial posterior wall contiguous to the anterior
esophageal wall can be imaged in each case. This imaging
technique can provide real-time anatomic imaging of this region (3).
In addition to anatomic imaging of this region, the ablation catheter
tip location and creation of echogenic lesions can also be evaluated
during real-time ICE imaging (4). The ICE imaging can guide
changes in the energy-delivery strategy to protect the esophagus
from damage during ablation in this region and allow for safe
lesion delivery in closer proximity to the esophagus than can be
safely recommended with the barium ingestion–cine-fluoroscopic
imaging technique.
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REPLY
Our study (1) describes a simple, practical, and inexpensive
method to visualize the position of the esophagus in relation to the
left atrium during left atrial catheter ablation in real-time. We have
the following responses to the points raised by Dr. Ren and
colleagues:
1. Because the barium paste typically remains in the esophagus
for45 to 60 min, fluoroscopic imaging of the esophagus after
a barium swallow is indeed real-time, and the anterior part of
the esophagus is easily visualized.
2. Although there may be gaps in the continuity of mucosal
staining after barium is swallowed, one can usually simply
extrapolate from the more proximal to distal segments of the
esophagus.
3. Although it is possible that barium swallow may facilitate
esophageal peristalsis, patients swallow their own saliva during
procedures performed under conscious sedation. Furthermore,
as already discussed in our study (1) there was no correlation
between the prevalence and extent of esophageal peristalsis and
the amount of barium swallowed.
4. Aspiration has not occurred during or after barium swallow in
over 500 patients who underwent left atrial catheter ablation
under conscious sedation in our electrophysiology laboratory.
5. Figures 1A and 1B (1) are identical anteroposterior projections
randomly chosen from many examples of esophageal migration.
As seen in Figure 1 (1), there is marked migration of the
esophagus. This clearly is not an illusion.
Finally, we do not dispute that intracardiac echocardiography
also may be used for real-time monitoring of the esophagus.
However, we find the barium swallow to be much simpler and
practical than intracardiac echocardiography.
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Chronotropic Incompetence in Heart Failure
The relationship between heart rate (HR) during exercise and
exercise capacity in patients with heart failure due to left ventric-
ular systolic dysfunction remains unclear. The accepted diagnostic
criterion for chronotropic incompetence (CI), a maximum age-
predicted heart rate (MA-PHR) 85%, is seen in 50% of patients
with severe heart failure on contemporary medical therapy (1).
Whether the lesser HR rise is the cause of the exercise impairment
is less certain: as HR increases as a function of exercise load, it is
inevitable that HR at peak exercise will be lower in subjects with
worse exercise capacity.
Tse et al. (2) are to be congratulated in trying to explore these
issues in their study of patients with cardiac resynchronization
devices. However, some important issues were raised by their
suggestion that rate-adaptive pacing might be more widely used in
patients with resynchronization devices. In patients with the most
severe CI, defined as failure to reach 70% of age-predicted
maximum HR (n  11), Tse et al. were able to demonstrate an
increase in exercise capacity with rate-adaptive pacing. There are
no published data on the incidence of their chosen value of 70%,
although it was seen in 28% of patients in our dataset (1).
At first sight, this seems a useful incremental benefit. However,
using the more widely accepted definition of failure to achieve 85%
of age-predicted maximal HR (3), there was no benefit of rate
response pacing. In fact, in one-third of patients with less severe CI
(MA-PHR 70% to 85%), there was a reduction in exercise capacity
with rate response pacing.
Although CI in chronic heart failure (CHF) patients not taking
beta-blockers predicts a worse prognosis (1), lower HRs at rest are
associated with improved outcomes in beta-blocker–treated indi-
viduals (4). We have also previously demonstrated that HR
lowering by aggressive use of beta-blockers does not reduce
exercise capacity (1,5). Hence, the issue of CI in patients with
severe CHF is not resolved. Furthermore, the long-term effects of
rate response pacing and the consequent higher average HR on
mortality and left ventricular function are unknown. It is too early
to suggest that patients undergoing CRT should have their device’s
rate response function active.
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REPLY
We thank Drs. Witte and Clark for their interest in our study (1).
We agree with their comment that there is no established
diagnostic criterion for chronotropic incompetence (CI) for pa-
tients with heart failure (HF). The commonly used definition of
the age-predicted heart rate (HR) to diagnose CI is traditionally
employed for patients with ischemic heart disease. Despite the
wide application of rate-adaptive pacing, there is also no estab-
lished definition of CI for pacemaker patients (2). From a pacing
standpoint, the detection of CI is clinically relevant only when
there is a functional improvement associated with rate-adaptive
pacing. Prior studies have shown that HF patients with CI have
lower peak oxygen consumption as compared with those without
CI (3). Our data demonstrate that the conventional definition of
CI is not applicable to patients with HF implanted with cardiac
resynchronization therapy (CRT). Indeed, rate-adaptive pacing
was found to be beneficial only in those patients with severe CI
who failed to achieve 70% of age-predicted HR, and potentially
harmful to patients with mild CI based on the conventional
definition. Furthermore, the incidence of CI in HF patients
implanted with CRT appears to be higher than for those reported
in the general HF population (4). We have evaluated a total of 28
patients and have enrolled 20 patients (71%) with age-predicted
HR 85% for this study. This is likely because the current CRT
patients have more severe HF (class III to IV) and advanced
conduction system abnormalities as compared with the general HF
population.
As mentioned by Drs. Witte and Clark, a lower HR at rest
predicts better outcome in patients treated with a beta-blocker.
The use of rate-adaptive pacing only increases HR during exercise,
but not the resting HR, and the increase in 24-h HR due to
rate-adaptive pacing is minimal. In fact, the use of rate-adaptive
pacing can alleviate the CI to allow more aggressive use of
beta-blockers. Consistent with the findings in their recent studies
(4), we have shown that the percentage of HR changes during
exercise positively correlated with peak oxygen consumption (1).
We believe that our data have demonstrated that rate-adaptive
pacing is complementary to the use of CRT and optimal medical
therapy, including beta-blocker, to improve exercise capacity in
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